Menascu S, Fattal-Valevski A, Vaknin-Dembinsky A, Milo R, et al. Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stage. J Neurol Sci 2021;432:120074.
PMID: 34875473